Exhibit 32.2

              SECTION 906 CERTIFICATION OF CHIEF FINANCIAL OFFICER

                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In  connection  with  the  quarterly  report  (the  "Report")  of China
Biopharmaceuticals Holdings, Inc. (the "Company") on Form 10-QSB for the quarter
ended March 31, 2006 as filed with the Securities and Exchange Commission on the
date hereof, I, HUANG Chentai, Chief Financial Officer of the Company,  certify,
pursuant to 18 U.S.C. 1350, as adopted pursuant to 906 of the Sarbanes-Oxley Act
of 2002, that to my knowledge:

1.       The Report fully  complies  with the  requirements  of section 13(a) or
         15(d) of the Securities Exchange Act of 1934; and

2.       The  information  contained  in  the  Report  fairly  presents,  in all
         material respects, the financial condition and results of operations of
         the Company.



Date: May 18, 2006                                    By: /s/ HUANG Chentai
                                                         -----------------------
                                                         HUANG Chentai
                                                         Chief Financial Officer